However, research has shown that condom use is linked to lower cer- vical cancer rates. Protect yourself with a condom every time you have vaginal, anal, or oral sex. Q: How often should I get a Pap test? A: Follow these guidelines: • Have a Pap test every 2 years starting...
Screening for Cervical Cancer in Primary Care: A Decision Analysis for the US Preventive Services Task Force. Rockville, MD: Agency for Healthcare Research and Quality; 2018. AHRQ publication 15-05224-EF-2. 4. Melnikow J, Henderson JT, Burda BU, Senger CA, Durbin S, Weyrich MS. Screening...
Recently, The Food and Drug Administration (FDA) took a step forward to introduce new mechanisms for approval of NGS tests in cancer therapy especially CC [106]. One of the largest comprehensive genomic studies reported so far was by The Cancer Genome Atlas Research Network. They performed ...
Screening for Cervical Cancer: A Systematic Evidence Review for the U.S. Preventive Services Task Force. Rockville, MD: Agency for Healthcare Research and Quality; 2011. AHRQ publication 11-05156-EF-1. 12. Canfell K, Caruana M, Gebski V, et al. Cervical screening with primary HPV testing...
Egger Damian J. Ralser Journal of Cancer Research and Clinical Oncology (2023) Immunotherapy in Cervical Cancer Dennis Mauricio Burak Zeybek Alessandro D. Santin Current Oncology Reports (2021)Download PDF Sections Figures References Abstract Introduction Materials and Methods Results Discussion ...
This study aims to reveal the risk factors associated with recurrence or new-onset high-grade squamous intraepithelial lesions (HSILs) or more severe lesions (HSILs +) and analyze obstetrical outcomes in patients with adenocarcinoma in situ (AIS) or stage IA1 cervical cancer patients after coni...
Promoter hypermethylation of FANCF: disruption of Fanconi Anemia-BRCA pathway in cervical cancer. Patients with advanced stage invasive cervical cancer (CC) exhibit highly complex genomic alterations and respond poorly to conventional treatment protocol... Narayan,G. - 《Cancer Research》 被引量: 945发...
Cervical cancer (CC) represents the third most commonly diagnosed cancer and the fourth cause of cancer death in women worldwide [GLOBOCAN: Estimated cancer incidence, mortality and prevalence worldwide in 2012 international agency for research on cancer; 2012. Available at: http://globocan.iarc....
Screening for Cervical Cancer With High-Risk Human Papillomavirus Testing: A Systematic Evidence Review for the U.S. Preventive Services Task Force: Evidence Synthesis No. 158. Rockville, MD: Agency for Healthcare Research and Quality; 2017. AHRQ publication 17-05231-EF-1. 6. Campos NG, Burger...
Conclusions and Relevance Among women undergoing cervical cancer screening, the use of primary HPV testing compared with cytology testing resulted in a significantly lower likelihood of CIN3+ at 48 months. Further research is needed to understand long-term clinical outcomes as well as cost-effectivenes...